Cite

3-MONTH INTERIM RESULTS OF A PHASE 4, REAL-WORLD STUDY (COMPOSUR) TO EVALUATE VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER

MLA

S MacDiarmid, et al. “3-Month Interim Results of a Phase 4, Real-World Study (Composur) to Evaluate Vibegron in Patients with Overactive Bladder.” Continence, vol. 7, no. 100750-, Sept. 2023. EBSCOhost, https://doi.org/10.1016/j.cont.2023.100750.



APA

S MacDiarmid, R Dmochowski, E Rovner, M Kennelly, D Newman, L Abedinzadeh, D Snyder, & E Thomas. (2023). 3-Month Interim Results of a Phase 4, Real-World Study (Composur) to Evaluate Vibegron in Patients with Overactive Bladder. Continence, 7(100750-). https://doi.org/10.1016/j.cont.2023.100750



Chicago

S MacDiarmid, R Dmochowski, E Rovner, M Kennelly, D Newman, L Abedinzadeh, D Snyder, and E Thomas. 2023. “3-Month Interim Results of a Phase 4, Real-World Study (Composur) to Evaluate Vibegron in Patients with Overactive Bladder.” Continence 7 (100750-). doi:10.1016/j.cont.2023.100750.